David Hallal Insider Trading Transactions
Get free email notifications about insider trading for David Hallal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Hallal. David Hallal is CEO in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Operating Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Commercial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm. Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP Commercial Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commerical Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Seer, Inc. ($SEER) and Director in Scholar Rock Holding Corp ($SRRK) and Chief Executive Officer in Allovir, Inc. ($ALVR) and Director in iTeos Therapeutics, Inc. ($ITOS).
Latest Insider Trading Transactions of David Hallal
Sentiment: All, ALXN, ALVR, ITOS, SRRK, SEER
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 29 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 13,616 | 222,213 | 19,512 | |
Dec 29 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 79.33 | 13,616 | 1,080,157 | 8,770 | 22.4 K to 8.8 K (-60.82 %) |
Dec 29 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 13,616 | 222,213 | 22,386 | 8.8 K to 22.4 K (+155.26 %) |
Dec 28 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 2,500 | 40,800 | 30,628 | |
Dec 28 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 2,500 | 40,800 | 11,270 | 8.8 K to 11.3 K (+28.51 %) |
Dec 15 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 5,000 | 81,600 | 33,128 | |
Dec 15 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 5,000 | 81,600 | 8,770 | 3.8 K to 8.8 K (+132.63 %) |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 20,000 | 326,400 | 13,616 | |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 70.29 | 20,000 | 1,405,800 | 3,770 | 23.8 K to 3.8 K (-84.14 %) |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 20,000 | 326,400 | 23,770 | 3.8 K to 23.8 K (+530.50 %) |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 70.42 | 1,000 | 70,420 | 3,770 | 4.8 K to 3.8 K (-20.96 %) |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 70.43 | 1,619 | 114,026 | 4,770 | 6.4 K to 4.8 K (-25.34 %) |
Jul 19 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 51.08 | 227 | 11,595 | 6,389 | 6.6 K to 6.4 K (-3.43 %) |
Jul 13 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 51.91 | 238 | 12,355 | 6,616 | 6.9 K to 6.6 K (-3.47 %) |
Jun 21 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 54.81 | 916 | 50,206 | 6,854 | 7.8 K to 6.9 K (-11.79 %) |
Mar 04 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 10,000 | 163,200 | 58,128 | |
Mar 04 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 51.80 | 10,000 | 518,000 | 7,770 | 17.8 K to 7.8 K (-56.27 %) |
Mar 04 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 10,000 | 163,200 | 17,770 | 7.8 K to 17.8 K (+128.70 %) |
Feb 18 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 47.93 | 6,242 | 299,179 | 7,770 | 14 K to 7.8 K (-44.55 %) |
Feb 01 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | A | 45.80 | 50,000 | 2,290,000 | 50,000 | |
Feb 01 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Grant | A | 0.00 | 6,000 | 0 | 14,012 | 8 K to 14 K (+74.89 %) |
Jan 21 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 47.22 | 227 | 10,719 | 8,012 | 8.2 K to 8 K (-2.76 %) |
Jan 12 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 47.78 | 1,088 | 51,985 | 8,239 | 9.3 K to 8.2 K (-11.67 %) |
Dec 21 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 47.79 | 916 | 43,776 | 9,327 | 10.2 K to 9.3 K (-8.94 %) |
Dec 15 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 10,000 | 163,200 | 68,128 | |
Dec 15 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 46.40 | 10,000 | 464,000 | 10,243 | 20.2 K to 10.2 K (-49.40 %) |
Dec 15 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 10,000 | 163,200 | 20,243 | 10.2 K to 20.2 K (+97.63 %) |
Jul 28 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Sr. VP Comm Ops, Am ... | Sell | S | 43.00 | 8,640 | 371,520 | 10,243 | 18.9 K to 10.2 K (-45.76 %) |
Jul 17 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Sr. VP Comm Ops, Am ... | Sell | S | 38.96 | 238 | 9,272 | 18,883 | 19.1 K to 18.9 K (-1.24 %) |
Jun 23 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Sr. VP Comm Ops, Am ... | Sell | S | 38.47 | 789 | 30,353 | 19,121 | 19.9 K to 19.1 K (-3.96 %) |
Jun 12 2009 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Sr. VP Comm. Ops, A ... | Sell | S | 38.00 | 3,590 | 136,420 | 19,910 | 23.5 K to 19.9 K (-15.28 %) |